Fauci says debate on Covid origins has been ‘seriously distorted’

The former top U.S. infectious disease official on Monday came out forcefully against GOP accusations on a host of Covid-related issues

June 3, 2024 Check out STAT+

Sponsored By

STAT is putting together a list of books and podcasts that deal with health, medicine, and the life sciences that would be great to check out this summer. Submit your reader recommendation here!

Chip Somodevilla/Getty Images Anthony Fauci, facing GOP accusers, says debate on Covid origins has been 'seriously distorted' Fauci says tenor of lab-leak origin story is "simply preposterous," spars with Republican congressional committee on coronavirus gain-of-function research. By Sarah Owermohle STAT+ | ASCO24: AstraZeneca won cancer's big meeting — again. Will that help it fulfill its $80 billion ambition? It's a harsh reality in the pharmaceutical business that winning streaks tend to end —– and cruelly. But AstraZeneca believes it has reason for optimism. By Matthew Herper STAT+ | Elevance PBM's president out as customers complain of prescription chaos The customer complaints coincide with major changes at CarelonRx, as Elevance juggles pharmacy delivery company switchovers. By Brittany Trang Adobe STAT+ | Which hospital systems will join Kaiser's Risant next? Kaiser's Risant Health acquired Geisinger in a mega-deal last year. Three health systems look like prime candidates for its next takeover. By Bob Herman Study finds BMI, despite flaws, is useful estimate of body fat in children While imperfect in distinguishing between fat and lean mass, BMI was effective at its higher end as an indicator of high body fatness. By Elizabeth Cooney STAT+ | Physicians take Medicare Advantage to task for rural patients' care gaps Comments from doctors, home health and hospice providers, medical device suppliers, and hospitals detail failures in Medicare Advantage. By Tara Bannow Drew Angerer/Getty Images STAT+ | Structure Therapeutics oral GLP-1 drug led to weight loss in two studies The results appear to approach the levels of weight loss seen at 12 weeks in a separate Phase 2 study of Eli Lilly's GLP-1 pill called orforglipron. By Elaine Chen STAT+ | Delfi Diagnostics announces key data, study design for its liquid biopsy test Delfi is focusing on a single disease — lung cancer — where the utility of screening with existing technology is not in dispute. By Matthew Herper

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser